Asthma Therapy II: Steroids, Bronchodilators, Other Therapies

681

Efficacy and Safety of Albuterol Multidose Dry Powder Inhaler (MDPI) Versus Placebo in Children With Asthma
Craig LaForce, MD, CPI Herminia Taveras, PhD, MPH Harald Iverson, PhD Paul Shore, MD, MS Tushar P Shah, MD

682

Effects of Roflumilast on Airway Hyperresponsiveness (AHR)
Robert G. Townley, MD FAAAAI Swati Agrawal, MBBS Mina R Hanna, MS Bryston Y Chang, BS Peter J Oldenburg, PhD

683

Montelukast Is a Better Controller in Obese Atopic Asthmatics
Sherry Farzan, MD Sundas Khan, MD Claudia Elera Meredith Akerman, MS

684

Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy Demonstrates Improved Asthma Control in Patients with Symptomatic Asthma, Independent of Serum IgE or Blood Eosinophil Levels
Mark L. Vandewalker, MD Johann Christian Virchow, MD Thomas B. Casale, MD FAAAAI Michael Engel, MD Petra Moroni-Zentgraf, MD Reinhold Lühmann, PhD Ronald Dahl, MD

685

Feasibility of Using Treatment Response Thresholds for Lung Function and Asthma Symptom Variables As Indicators of Asthma Control in Patients with Moderate to Severe Asthma
David J. Slade Michael DePietro John Horton Donald P. Tashkin, MD Bradley E. Chipps, MD FAAAAI

686

Dose-Ranging Efficacy and Safety Study of Albuterol Multidose Dry Powder Inhaler (MDPI) vs Albuterol Hydrofluoroalkane (HFA) and Placebo MDPI in Children With Asthma
Paul Y Qaqundah, MD Herminia Taveras, PhD, MPH Harald Iverson, PhD Paul Shore, MD, MS Tushar P Shah, MD

687

Comparison of Treatment Modalities for Inpatient Asthma Exacerbation Among U.S. Pediatric Hospitals
Meredith A. Dilley, MD William J. Sheehan, MD Dionne Graham, PhD Carter Petty, MA Wanda Phipatanakul, MD MS FAAAAI

688

Unsuccessful Aspirin Desensitization in Minority Patients with AERD: Association with Increased Eosinophilia and Sinus Surgery Timing.
Elina Jerschow, M.D., M.Sc. Teresa Pelletier, B.A. Ren Zhen Robert Tamayev, M.D., Ph.D. Waleed Abuzeid, M.D. Marvin Fried, M.D. Golda Hudes, M.D. PhD Esperanza Morales Krista Nelson, B.F.A. Jonathan Feldman, PhD Victor Schuster, M.D. Simon Spivack, M.D., M.P.H. David L. Rosenstreich, MD FAAAAI

689

Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy in Patients with Symptomatic Asthma: Methodology of Modeling Analyses By Serum IgE and Blood Eosinophil Levels
Hendrik Schmidt, PhD Petra Moroni-Zentgraf, MD Michael Engel, MD Ronald Dahl, MD Huib A.M. Kerstjens, MD

690

Monthly Triamcinolone Acetonide for Severe, Refractory, Life-Threatening Asthma in Children
Nadia L. Krupp, MD Andrea Weist, M.D. Cindy Fiscus, R.N.

691

Inhaled High Dose Budesonide Is As Effective As Systemic Corticosteroids for Children Under Three with Mild Asthma Exacerbations
Mari Saito Yutaka Kikuchi Masaru Hoshina

692

Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy Demonstrates Improved Lung Function in Patients with Symptomatic Asthma, Independent of Serum IgE or Blood Eosinophil Levels
Donald P. Tashkin, MD Ronald Dahl, MD Johann Christian Virchow, MD Michael Engel, MD Petra Moroni-Zentgraf, MD Liliana Zaremba-Pechmann, PhD Huib A.M. Kerstjens, MD

693

Controller Montelukast to Prevent Asthma-like Exacerbation in Preschool Children with Recurrent Wheeze
Mizuho Nagao Takao Fujisawa, MD PhD FAAAAI Toshio Katsunuma, MD, PhD Shigemi Yoshihara, MD PhD Yuhei Hamasaki, MD, PhD

694

Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the Tenor II Cohort
Larry Borish, MD FAAAAI Stanley J. Szefler, MD FAAAAI Robert S. Zeiger, MD PhD FAAAAI Aimee Foreman, MA Steve Greenberg, MD Tmirah Haselkorn Farid Kianifard, PhD Meryl Mendelson, MD Brandee Paknis, PharmD Scott T. Weiss , MD MS Bradley E. Chipps, MD FAAAAI

695

Mometasone Furoate (MF) Improves Lung Function in Pediatric Asthma: A Dose-Ranging Study of MF Metered-Dose Inhaler (MDI)
Niran J. Amar, MD FAAAAI Tulin Shekar, MS Tracey Varnell Anish Mehta George Philip, MD

696

Tiotropium Respimat® Add-on to at Least Ics Therapy Demonstrates Reduced Risk of Severe Asthma Exacerbation and Asthma Worsening in Symptomatic Asthma, Independent of IgE or Blood Eosinophil Levels
Thomas B. Casale, MD FAAAAI Donald P. Tashkin, MD Reinhold Lühmann, PhD Michael Engel, MD Petra Moroni-Zentgraf, MD Huib A.M. Kerstjens, MD

697

A Retrospective Study of the Effect of Antifungal Therapy on a Cohort with Asthma and Chronic Rhinosinusitis
Evan Li, MD Rani Maskatia, MD Paul Porter, PhD David B. Corry, MD

698

Differences in Oral Corticosteroid Prescribing Regimens for Asthma Exacerbations Between Primary Care and Specialty Pediatricians
Kara McNamara, MD David R. Stukus, MD FAAAAI

699

No Significant Growth Velocity Changes in Two Trials Evaluating the Potential Effects of Flunisolide HFA (AerospanTM) on Growth in Pediatric Patients with Mild-to-Moderate Asthma
George W. Bensch, MD FAAAAI David P. Skoner, MD

700

Variation of in Vitro Glucocorticoid Response in Asthma
Monica B. Reddy, MD Donald Y.M. Leung, MD PhD FAAAAI Joseph D. Spahn, MD Douglas Curran-Everett, PhD Vijaya Knight, MD, PhD Ronina A. Covar, MD FAAAAI

701

Growth Effects of Concomitant Inhaled (ICS) and Intranasal (INCS) Corticosteroid (CS) Use in Children.
David P. Skoner, MD Deborah A. Gentile, MD Nicole Pleskovic, BS Erica Butler, BS,CCRC Asha Patel, M.S.